
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| MB_CA_L | 248 | 59.8% | 2.44 | 1,345 | 71.4% |
| LH_L | 97 | 23.4% | 1.18 | 220 | 11.7% |
| SLP_L | 8 | 1.9% | 5.25 | 305 | 16.2% |
| PLP_L | 51 | 12.3% | -2.21 | 11 | 0.6% |
| PVLP_L | 7 | 1.7% | -2.81 | 1 | 0.1% |
| ME_L | 3 | 0.7% | -1.58 | 1 | 0.1% |
| AVLP_L | 1 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns SLP184 | % In | CV |
|---|---|---|---|---|---|
| VP3+_vPN (L) | 1 | GABA | 151 | 39.2% | 0.0 |
| SLP184 (L) | 1 | ACh | 57 | 14.8% | 0.0 |
| DN1-l (L) | 1 | Glu | 13 | 3.4% | 0.0 |
| M_ilPNm90,M_ilPN8t91 (L) | 1 | ACh | 12 | 3.1% | 0.0 |
| MTe51 (L) | 8 | ACh | 12 | 3.1% | 0.3 |
| DN1a (L) | 2 | Glu | 8 | 2.1% | 0.2 |
| CB1321 (L) | 3 | ACh | 8 | 2.1% | 0.5 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 7 | 1.8% | 0.0 |
| LC45 (L) | 1 | ACh | 6 | 1.6% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 6 | 1.6% | 0.0 |
| CB1511 (L) | 3 | Glu | 6 | 1.6% | 0.4 |
| SMP421 (L) | 1 | ACh | 5 | 1.3% | 0.0 |
| M_ilPNm90,M_ilPN8t91 (R) | 1 | ACh | 5 | 1.3% | 0.0 |
| VP4_vPN (L) | 1 | GABA | 4 | 1.0% | 0.0 |
| CB1178 (L) | 1 | Glu | 3 | 0.8% | 0.0 |
| LHPV6q1 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| aMe26 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| LHAV3o1 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| PLP198,SLP361 (L) | 2 | ACh | 3 | 0.8% | 0.3 |
| LHAV3f1 (L) | 1 | Glu | 2 | 0.5% | 0.0 |
| WED092c (L) | 1 | ACh | 2 | 0.5% | 0.0 |
| SLP457 (L) | 1 | Unk | 2 | 0.5% | 0.0 |
| SLP373 (L) | 1 | ACh | 2 | 0.5% | 0.0 |
| PPL203 (L) | 1 | DA | 2 | 0.5% | 0.0 |
| LHPV6m1 (L) | 1 | Glu | 2 | 0.5% | 0.0 |
| KCapbp-ap1 (L) | 2 | ACh | 2 | 0.5% | 0.0 |
| MTe03 (L) | 2 | ACh | 2 | 0.5% | 0.0 |
| CB3555 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB3676 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LC28a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1660 (L) | 1 | Unk | 1 | 0.3% | 0.0 |
| SMP045 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| AVLP571 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPD5a1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.3% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP086b (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| AVLP594 (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| CB3308 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB3016 (L) | 1 | Unk | 1 | 0.3% | 0.0 |
| CB3206 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LTe46 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB2022 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHAD4a1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPD1b1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| PLP064_b (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP210 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV4c3, LHPV4c4 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB3383 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2879 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHCENT8 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| s-LNv_a (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| LHAV5e1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| AVLP303 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1733 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| SLP358 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV4c4 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| OA-AL2b1 (R) | 1 | OA | 1 | 0.3% | 0.0 |
| mALD2 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| SMP345 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB2616 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP095 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LTe22 (L) | 1 | Unk | 1 | 0.3% | 0.0 |
| 5-HTPMPV01 (R) | 1 | Unk | 1 | 0.3% | 0.0 |
| PLP177 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB0670 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP403 (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| AVLP313 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1318 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV1c2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB3709 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB3071 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV4h1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB2377 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns SLP184 | % Out | CV |
|---|---|---|---|---|---|
| DN1a (L) | 2 | Glu | 90 | 13.4% | 0.1 |
| SLP184 (L) | 1 | ACh | 57 | 8.5% | 0.0 |
| SMP345 (L) | 2 | Glu | 40 | 6.0% | 0.6 |
| LHPD5a1 (L) | 1 | Glu | 36 | 5.4% | 0.0 |
| LHAV3q1 (L) | 1 | ACh | 34 | 5.1% | 0.0 |
| KCg-s2 (L) | 1 | ACh | 32 | 4.8% | 0.0 |
| SMP421 (L) | 1 | ACh | 29 | 4.3% | 0.0 |
| LHPV4c3, LHPV4c4 (L) | 2 | Glu | 25 | 3.7% | 0.3 |
| CB3174 (L) | 3 | ACh | 25 | 3.7% | 0.5 |
| LHPV6h1 (L) | 3 | ACh | 22 | 3.3% | 0.5 |
| SLP210 (L) | 1 | ACh | 20 | 3.0% | 0.0 |
| SMP427 (L) | 2 | ACh | 20 | 3.0% | 0.8 |
| SLP373 (L) | 1 | ACh | 16 | 2.4% | 0.0 |
| CB1218 (L) | 1 | Glu | 16 | 2.4% | 0.0 |
| SLP066 (L) | 1 | Glu | 16 | 2.4% | 0.0 |
| SMP235 (L) | 1 | Glu | 16 | 2.4% | 0.0 |
| SMP201 (L) | 1 | Glu | 15 | 2.2% | 0.0 |
| CB1511 (L) | 2 | Glu | 14 | 2.1% | 0.4 |
| DN1-l (L) | 1 | Glu | 12 | 1.8% | 0.0 |
| SLP364 (L) | 2 | Glu | 11 | 1.6% | 0.1 |
| LHAV3c1 (L) | 1 | ACh | 9 | 1.3% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 8 | 1.2% | 0.0 |
| CB2269 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| CB3755 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| LHPV6m1 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| LHPV4c4 (L) | 3 | Glu | 6 | 0.9% | 0.4 |
| VP3+_vPN (L) | 1 | GABA | 5 | 0.7% | 0.0 |
| CB3248 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| CB3765 (L) | 1 | Glu | 4 | 0.6% | 0.0 |
| CB2076 (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| CB3753 (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| SLP358 (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| SMP426 (L) | 2 | Glu | 3 | 0.4% | 0.3 |
| SMP528 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP387 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SMP527 (L) | 1 | Unk | 2 | 0.3% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CL087 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CB0102 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| cM08c (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHPV6f1 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CB2901 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| LC28a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1215 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP530 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| s-LNv_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VM4_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3449 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3556 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV8c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3206 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LC40 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL090_c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1744 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LTe67 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP459 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP463 (R) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| PLP069 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| WEDPN12 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1317 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB0386 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPD2d2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1947 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3383 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2616 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP209 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| KCapbp-ap1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP304a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_vPNml53 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHPV6r1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2907 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP403 (L) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| CB1153 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| APDN3 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LC28b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3709 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3071 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| DNpe035 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP214 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| M_lvPNm48 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1321 (L) | 1 | ACh | 1 | 0.1% | 0.0 |